Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 58, Issue 4, Pages 1217-1228
Publisher
IOS Press
Online
2017-05-27
DOI
10.3233/jad-161309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline
- (2016) Stefan Sturm et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Neuropsychiatric Symptoms as Predictors of Progression to Severe Alzheimer’s Dementia and Death: The Cache County Dementia Progression Study
- (2015) Matthew E. Peters et al. AMERICAN JOURNAL OF PSYCHIATRY
- Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients
- (2015) Nicola De Stefano et al. Multiple Sclerosis Journal
- Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients
- (2015) Nicola De Stefano et al. Multiple Sclerosis Journal
- The BEHAVE-AD Assessment System: A Perspective, A Commentary on New Findings, and A Historical Review
- (2014) Barry Reisberg et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Brain atrophy in natalizumab-treated patients: A 3-year follow-up
- (2014) J Sastre-Garriga et al. Multiple Sclerosis Journal
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical characterization of RO4602522, a novel, selective and orally active monoamine oxidase type B inhibitor for the treatment of Alzheimer's disease
- (2013) Edilio Borroni et al. Alzheimers & Dementia
- Brain MAO-B inhibition in healthy elderly and people with Alzheimer's disease after oral administration of RO4602522
- (2013) Benedicte Ricci et al. Alzheimers & Dementia
- Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review
- (2012) Dallas P. Seitz et al. INTERNATIONAL PSYCHOGERIATRICS
- Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients
- (2012) Maria Zellner et al. Journal of Proteomics
- A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch
- (2012) Ivan Berlin et al. PSYCHOPHARMACOLOGY
- Neuropsychiatric symptoms in Alzheimer’s disease
- (2011) Constantine G. Lyketsos et al. Alzheimers & Dementia
- The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
- (2011) Kelly Posner et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease
- (2010) Robert A. Mitchell et al. CNS Neuroscience & Therapeutics
- Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-l-deprenyl using whole hemisphere autoradiography
- (2010) Balázs Gulyás et al. NEUROCHEMISTRY INTERNATIONAL
- Disease progression meta-analysis model in Alzheimer's disease
- (2009) Kaori Ito et al. Alzheimers & Dementia
- MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
- (2008) Jyothi K. Mallajosyula et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now